Patent · US Active

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

US9695120B2 · kind B2 · utility

1Cited by

5References

36Claims

0Family size

Assignee

Ogeda SA · BE

Inventors

Hamid R. Hoveyda · Brussels, BE
Didier Schils · Loupoigne, BE
Ludivine Zoute · Vedrin, BE
Julien Parcq · Lille, FR

Key dates

Filing date	Jun 18, 2012
Grant date	Jul 4, 2017
Priority date	—
Expiry date	Dec 4, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel pyrrolidine carboxylic acid derivatives, pharmaceutical compositions, and their use in treating and/or preventing metabolic diseases as agonists of g-protein coupled receptor 43.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.